INS and type 2 diabetes mellitus: White et al. employed immunofluorescence examination of three human T2D donor pancreata to reveal numerous insulin+ cells that co-localized with glucagon or the vimentin mesenchymal marker (White et al., 2013), suggesting altered β-cell identity.